Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Rezolute Inc (RZLT)

Rezolute Inc (RZLT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 176,995
  • Shares Outstanding, K 40,135
  • Annual Sales, $ 0 K
  • Annual Income, $ -51,790 K
  • 60-Month Beta 1.20
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 2.63
Trade RZLT with:

Options Overview Details

View History
  • Implied Volatility 87.83% ( -35.66%)
  • Historical Volatility 99.65%
  • IV Percentile 77%
  • IV Rank 38.22%
  • IV High 198.65% on 06/13/24
  • IV Low 19.26% on 07/03/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 95
  • Volume Avg (30-Day) 21
  • Put/Call OI Ratio 0.37
  • Today's Open Interest 349
  • Open Int (30-Day) 249

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.30
  • Number of Estimates 2
  • High Estimate -0.26
  • Low Estimate -0.34
  • Prior Year -0.25
  • Growth Rate Est. (year over year) -20.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.67 +23.16%
on 06/20/24
5.12 -11.72%
on 07/17/24
+0.64 (+16.49%)
since 06/18/24
3-Month
2.48 +82.26%
on 05/16/24
6.10 -25.90%
on 06/05/24
+1.09 (+31.78%)
since 04/19/24
52-Week
0.72 +527.78%
on 11/30/23
6.10 -25.90%
on 06/05/24
+2.51 (+124.88%)
since 07/19/23

Most Recent Stories

More News
5 Biotech Stocks Under $10 With Multibagger Potential

As the biotech industry continues to redefine the healthcare landscape, here are five penny biotech stocks poised for meteoric growth in this evolving industry.

ADCT : 3.44 (-6.27%)
$SPX : 5,505.00 (-0.71%)
RZLT : 4.52 (+2.49%)
TRVI : 2.78 (+4.51%)
ELEV : 2.64 (-1.12%)
CRDL : 2.09 (+4.50%)
S&P Futures Tick Lower Ahead of FOMC Meeting Minutes, Nvidia Earnings in Focus

June S&P 500 E-Mini futures (ESM24) are trending down -0.11% this morning as market participants awaited minutes of the Federal Reserve’s latest policy meeting as well as an earnings report from artificial...

ESM24 : 5,471.89s (-0.09%)
FSLR : 216.43 (+1.33%)
TSLA : 239.20 (-4.02%)
IBM : 183.25 (-1.06%)
NDSN : 236.61 (-1.27%)
PANW : 330.89 (+2.16%)
NVDA : 117.93 (-2.61%)
TJX : 111.75 (-1.13%)
ADI : 231.22 (-3.25%)
TGT : 149.73 (-1.55%)
SNOW : 129.85 (+0.01%)
MKS.LN : 318.030 (+2.43%)
Rezolute Announces Promotion of Brian Roberts, M.D. to Chief Medical Officer

REDWOOD CITY, Calif., June 01, 2022 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT), a clinical-stage biopharmaceutical company dedicated to developing...

RZLT : 4.52 (+2.49%)
Rezolute to Host Corporate Update Call on May 4, 2022

Company to Host Analyst and Investor Conference Call on Wednesday, May 4 at 4:30 p.m. ET...

RZLT : 4.52 (+2.49%)
Rezolute, Inc. Announces Closing of Registered Direct Offering

REDWOOD CITY, Calif., May 04, 2022 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT), a clinical-stage biopharmaceutical company dedicated to developing...

RZLT : 4.52 (+2.49%)
Rezolute, Inc. Announces Aggregate $130 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market

REDWOOD CITY, Calif., May 01, 2022 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT), a clinical-stage biopharmaceutical company dedicated to developing...

RZLT : 4.52 (+2.49%)
Rezolute Announces Positive Data from its Phase 2b (RIZE) Study of RZ358 in Patients with Congenital Hyperinsulinism

Results Presented Today at the Pediatric Endocrine Society’s 2022 Annual Meeting...

RZLT : 4.52 (+2.49%)
Rezolute Joins the Rare Disease Company Coalition

Rezolute joins group aimed at helping advance timely access to life-saving therapies for those impacted by rare diseases...

RZLT : 4.52 (+2.49%)
Rezolute Announces Positive Results from the Phase 2b RIZE Study of RZ358 in Congenital Hyperinsulinism

The RIZE study demonstrated highly significant improvements in hypoglycemia and good safety and tolerability Results to be presented in an oral...

RZLT : 4.52 (+2.49%)
Rezolute Announces Positive Study Results for RZ402, an oral PKI being developed for DME

Phase 2 proof-of-concept study anticipated in 2H 2022...

RZLT : 4.52 (+2.49%)

Business Summary

Rezolute, Inc. is a biopharmaceutical company specializing in the development of drug therapies for metabolic and orphan diseases. The Company's products include AB101, RZ358, RZ402 and RZ602 which are in clinical stage. Rezolute, Inc., formerly known as AntriaBio, Inc., is based in LOUISVILLE, United...

See More

Key Turning Points

3rd Resistance Point 4.77
2nd Resistance Point 4.67
1st Resistance Point 4.59
Last Price 4.52
1st Support Level 4.41
2nd Support Level 4.31
3rd Support Level 4.23

See More

52-Week High 6.10
Last Price 4.52
Fibonacci 61.8% 4.04
Fibonacci 50% 3.41
Fibonacci 38.2% 2.78
52-Week Low 0.72

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar